Clinical Characteristics and Management of Checkpoint Inhibitor Pneumonitis in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Immunotherapy

Post time Half hour(s) ago

Revista: Clinical Lung Cancer

Autores: Long Jiang; Shanshan Jiang; Wang Miao; Yaofeng Shen; Larisa Bolotina; Hongda Zhu; Ningyuan Zou; Yu Tian; Hanbo Pan; Jia Huang; Andrey Ryabov; Qingquan Luo

Fecha de publicación: 2025-1-

DOI: 10.1016/j.cllc.2024.10.012

Enlace al PDF: https://www.sciencedirect.com/sc ... 525730424002298/pdf

Enlace al artículo: https://doi.org/10.1016/j.cllc.2024.10.012

Fuente del artículo: Elsevier BV .

Observación:

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] Clinical Characteristics and Management of Checkpoint Inhibitor Pneumonitis in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Immunotherapy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Clinical Characteristics and Management of Checkpoint Inhibitor Pneumonitis in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Immunotherapy Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Clinical Characteristics and Management of Checkpoint Inhibitor Pneumonitis in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Immunotherapy